Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis
AOD 9604 is a fragment of human growth hormone studied for its effect on fat metabolism, with a real but modest evidence base and an important regulatory caveat: it is not an FDA-approved weight loss drug
Mechanism Comparison The two peptides operate through entirely different biological mechanisms: BPC-157 mechanisms
One injection a day, typically at bedtime to match the natural growth-hormone release cycle
Fat Breakdown (Lipolysis) AOD-9604 promotes the breakdown of stored triglycerides into free fatty acids. This effect has been observed in adipose tissue from both lean and obese models
